The Biggest Loser: Celgene Selloff is Worst in Years
October 26, 2017 at 16:54 PM EDT
Shares of Celgene (CELG) plummeted to the bottom of the S&P 500 today after the drug maker cut its earnings forecasts for 2017 and cut its long-term financial targets. Celgene’s stock price fell almost 16.4% today to close the session at $99.63 a share, sinking below $100 for the first time since 2016. The drug […]
